Ursula A. Matulonis, MD, on Educating Patients About the Hematologic Risks of PARP Inhibitors

Posted: Monday, August 5, 2019

How do you talk to patients about the potential risk for myelodysplastic syndromes and acute myeloid leukemia when taking rucaparib and other PARP inhibitors?